An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAFV600E inhibitor-resistant metastatic melanoma cells-Reference-Cited by-同舟云学术

An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAFV600E inhibitor-resistant metastatic melanoma cells

Published:2017-07-28 Issue:9 Volume:13 Page:1512-1527
ISSN:1554-8627
Container-title:Autophagy
language:en
Short-container-title:Autophagy

Author:

Martin Shaun¹²,Dudek-Peric Aleksandra M.¹,Garg Abhishek D.¹^ORCID,Roose Heleen³,Demirsoy Seyma¹,Van Eygen Sofie¹,Mertens Freya³,Vangheluwe Peter²,Vankelecom Hugo³,Agostinis Patrizia¹

Affiliation:

1. Laboratory for Cell Death Research and Therapy, Department of Cellular and Molecular Medicine, University of Leuven (KU Leuven), Campus Gasthuisberg, Leuven, Belgium

2. Laboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, University of Leuven (KU Leuven), Campus Gasthuisberg, Leuven, Belgium

3. Department of Development and Regeneration, Cluster Stem Cell Biology and Embryology, University of Leuven (KU Leuven), Campus Gasthuisberg, Leuven, Belgium

Publisher

Informa UK Limited

Subject

Cell Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15548627.2017.1332550

Reference65 articles.

1. Prognostic factors for survival in melanoma patients with brain metastases

2. Vemurafenib: the first drug approved for BRAF-mutant cancer

3. Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic Targets

4. Why is autophagy important for melanoma? Molecular mechanisms and therapeutic implications

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Purinergic Ca2+ Signaling as a Novel Mechanism of Drug Tolerance in BRAF-Mutant Melanoma;Cancers;2024-06-30

2. A Redox-Triggered Autophagy-Induced Nanoplatform with PD-L1 Inhibition for Enhancing Combined Chemo-Immunotherapy;ACS Nano;2024-05-10

3. Development and in-depth characterization of BRAFi-resistant melanoma cell lines in vitro and in vivo;Experimental Cell Research;2024-05

4. Current State of Melanoma Therapy and Next Steps: Battling Therapeutic Resistance;Cancers;2024-04-19

5. A metastasis-associated Pannexin1 mutant (Panx1^1-89) forms a minimalist ATP release channel;2024-03-13